v1
ISIS-3 and GISSI-2: no survival advantage with tissue plasminogen activator over streptokinase, but a significant excess of strokes with tissue plasminogen activator in both trials.
Identifier:nobleid.org/w1/20260515/D71EB3C2
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/D71EB3C2)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims